Buscar
Mostrando ítems 1-10 de 308
Bleeding pattern and management of unexpected bleeding/spotting with an extended regimen of a combination of ethinylestradiol 20 mcg and drospirenone 3 mg
(2020-01-01)
Objective: To compare the bleeding pattern in women using ethinylestradiol 20 mcg/ drospirenone 3 mg (EE 20 mcg/DRSP 3 mg) in a 24/4-day cyclic regimen with an extended regimen. Unexpected bleeding/spotting in the extended ...
Bleeding patterns and menstrual-related symptoms with the continuous use of a contraceptive combination of ethinylestradiol and drospirenone: a randomized study
(ELSEVIER SCIENCE INC, 2010)
Background: The objective of this study was to compare bleeding patterns of women using a contraceptive combination of 30 mcg ethinylestradiol (EE) and 3 mg drospirenone (DRSP) continuously or cyclically. Menstrual-related ...
Bleeding complaints during the first year of Norplant(R) implants use and their impact on removal rate
(Butterworth-heinemannWoburn, 1996)
Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant (R) implants
(Oxford Univ PressOxfordInglaterra, 1998)
Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years
(Elsevier Science IncNew YorkEUA, 2002)
Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 μg and ethinylestradiol 15 μg (Minesse®)
(2006)
Objective: A prospective, open-label, noncomparative, multicenter study was carried out in 163 women aged 18–39 (mean 25±5 years), who used an ultra-low-dose oral contraceptive pill (OCP) containing gestodene (GTD) 60 ...